Long-term experience with the combination of pindolol and isradipine in essential hypertension
In: The American Journal of Medicine, Jg. 84 (1988-03-01), S. 4-7
Online
unknown
Zugriff:
Isradipine, a new dihydropyridine calcium antagonist with marked vascular selectivity, was given to 17 patients (11 men and six women, average age 56 ± 10 years) with essential hypertension for 12.5 months (range: four to 17 months). All had supine diastolic blood pressure more than 95 mm Hg with 10 mg pindolol once daily. After a short-term, double-blind, dose-finding, crossover comparison with addition of isradipine or placebo twice daily, they continued to receive pindolol and an optimal dose of isradipine in a single-blind, long-term, follow-up study. In the short-term study on the optimal dose of isradipine (5.1 mg twice daily), blood pressure was lowered by 2418 mm Hg (p
| Titel: |
Long-term experience with the combination of pindolol and isradipine in essential hypertension
|
|---|---|
| Autor/in / Beteiligte Person: | Andrén, Lennart ; Svensson, Anders ; Hansson, Lennart ; Eggertsen, Robert ; Jern, Sverker ; Dahlöf, Björn |
| Link: | |
| Zeitschrift: | The American Journal of Medicine, Jg. 84 (1988-03-01), S. 4-7 |
| Veröffentlichung: | Elsevier BV, 1988 |
| Medientyp: | unknown |
| ISSN: | 0002-9343 (print) |
| DOI: | 10.1016/0002-9343(88)90180-5 |
| Schlagwort: |
|
| Sonstiges: |
|